KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) EBIT (2016 - 2025)

Historic EBIT for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $334.0 million.

  • Xylem's EBIT rose 1928.57% to $334.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1930.75%. This contributed to the annual value of $1.0 billion for FY2024, which is 5475.46% up from last year.
  • Per Xylem's latest filing, its EBIT stood at $334.0 million for Q3 2025, which was up 1928.57% from $305.0 million recorded in Q2 2025.
  • In the past 5 years, Xylem's EBIT ranged from a high of $334.0 million in Q3 2025 and a low of $111.0 million during Q1 2022
  • Its 5-year average for EBIT is $196.7 million, with a median of $191.0 million in 2023.
  • The largest annual percentage gain for Xylem's EBIT in the last 5 years was 19629.63% (2021), contrasted with its biggest fall of 2178.77% (2021).
  • Over the past 5 years, Xylem's EBIT (Quarter) stood at $140.0 million in 2021, then soared by 40.71% to $197.0 million in 2022, then rose by 7.11% to $211.0 million in 2023, then increased by 26.54% to $267.0 million in 2024, then rose by 25.09% to $334.0 million in 2025.
  • Its last three reported values are $334.0 million in Q3 2025, $305.0 million for Q2 2025, and $231.0 million during Q1 2025.